Study shows rituximab effective in treating chronic graft-versus-host disease

Study shows rituximab effective in treating chronic graft-versus-host disease A study by Dana-Farber researchers offers the strongest evidence yet of the effectiveness of a novel therapy for chronic graft-versus-host disease (GVHD), a potentially life-threatening complication of donor bone marrow and stem cell transplants.